Takeda news

VELA's wind-powered trimaran will cut emissions by up to 99% for pharma shipping, ensuring cold-chain integrity and faster transatlantic delivery without invasive species transfer.

The new facility in Oranienburg, costing 100M euros, will start by end-2017, creating 180 jobs. It enhances production for global markets, supported by German and Brandenburg subsidies.

The new facility will expand Takeda's Grange Castle site, creating 40 jobs and producing NINLARO® for global markets. Construction starts June 2017, with operations beginning in late 2018.

The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.

The new plant in Singen will enhance dengue vaccine production, leveraging local expertise. Initial construction starts immediately, with production expected by 2019.